We have been granted the first U.S. patent in our company’s history. The patent covers a breakthrough discovered by the Dr Irena Eris Centre for Science and Research team: the synergistic effect of two ingredients – magnolol and honokiol – which has demonstrated exceptional effectiveness in relieving symptoms associated with irritated and sensitive skin.

The patented solution has been incorporated into the following products:

• Dr Irena Eris – the Sensi Science line and Dr Irena Eris
• SENSI LUME Serum Foundation SPF 50+/PA++++ (30 ml),
• Pharmaceris T – the Azelaic Acid Cream,
• Pharmaceris H – the new Trichology Scalp Peel,
• Emotopic – the Hydro-Micellar Shampoo.

It is also worth noting that in December 2024 we secured patent protection for this solution from the Polish Patent Office. This achievement is yet another testament to our strong scientific expertise and our consistent commitment to developing proprietary know-how and technological leadership. Receiving patent protection in the United States marks an important milestone in strengthening our position as a science-driven company with global ambitions.